Connect Biopharma(CNTB)
Focus: Connect Biopharma is a public-stage pharmaceutical company headquartered in San Diego focused on treatments for autoimmune diseases and inflammation, particularly in immunology. The company operates with a lean commercial footprint and heavy R&D investment.
Profile data last refreshed 3h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
5
Should You Work at Connect Biopharma?
AI assessmentHigh-risk, high-science opportunity suited for mission-driven R&D scientists willing to bet on early-stage immunology programs in a cash-constrained environment.
Why Work Here
- R&D-intensive culture with 112% R&D intensity and $29M spend in FY2025, suggesting deep commitment to pipeline advancement in immunology.
- Perfect H1B sponsorship record (9 approvals, 0 denials in 2023) indicates willingness to recruit global talent without visa friction.
Data completeness
6/9 — Partial
Company HealthStrong
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$26M
Key Products
Peak
Multiple formulations at peak lifecycle indicate established product portfolio, though clinical indication data is unavailable.
Help build intelligence for Connect Biopharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.